Navigation Links
IMRIS announces development program for MR guided radiation and interventional applications
Date:2/19/2009

WINNIPEG, Feb. 19 /PRNewswire-FirstCall/ - IMRIS Inc. (TSX: IM) ("IMRIS" or the "Company") today announced a five-year research initiative to focus on the development and commercialization of MR-guided radiation therapy and interventional procedures, working with the University Health Network (UHN) in Toronto.

The collaboration signals the entry of IMRIS into the field of image guided radiation therapy, expanding on its existing expertise in neurosurgery. IMRIS, a market leader in the field of advanced surgical MR imaging and UHN, with its specialized knowledge in imaging and radiation therapy, will focus on the creation of innovative technologies for radiation therapy. The clinical setting for research and testing of technologies will be Princess Margaret Hospital (PMH), UHN's world-leading cancer research hospital. The IMRIS 3T movable MR will be installed at PMH to enable the development of new approaches to radiation therapy using active MR guidance.

The goals of the collaboration include the development of new technologies, the establishment of clinical workflows and the validation of the benefits of MR guided radiation therapy technology to both the patient and the health system. Planned applications include the integration of the IMRIS technology with external beam radiation therapy, MR guided biopsies and brachytherapy of the prostate.

Dr. David Jaffray, Head of Radiation Physics at PMH, said: "MR is a powerful, non-invasive imaging modality that enables us to better target disease and avoid healthy tissues. This is the future of cancer treatment and we're hoping that working with IMRIS will take us there faster."

"We are extremely pleased to be working with a recognized leader in cancer treatment and research," said David Graves President and CEO of IMRIS. "This co-development agreement represents a tremendous opportunity and opens an entirely new application for the existing IMRIS platform used in Neurosurgery today."

About Princess Margaret Hospital:

Princess Margaret Hospital has achieved an international reputation as a global leader in the fight against cancer and is considered one of the top comprehensive cancer treatment and research centres in the world. Located in Toronto, Canada, PMH is the only facility in Canada devoted exclusively to cancer research, treatment and education.

About IMRIS:

IMRIS (TSX: IM) is a global leader in providing fully integrated, advanced surgical imaging solutions. The company's flagship product, IMRISneuro, utilizes patented technology that allows a high field MRI scanner to be moved in to the operating room on demand, providing imaging during the surgical procedure without compromising patient safety. This unique and innovative system has been validated by leading surgeons for use in world-class neuroscience centers.

For more information, visit www.imris.com


'/>"/>
SOURCE IMRIS Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. IMRIS announces first IMRISneuro project in Australia
2. IMRISneuro: The iMRI technology of choice among the worlds top ranked hospitals
3. IMRISneuro at Central DuPage Hospital will be the first in the Chicago area
4. Dell Childrens Medical Center to install IMRISneuro in expanded neurocenter
5. Senior GE Executive to lead IMRIS Sales team in the U.S.
6. University of Virginia Health System invests in IMRISneuro, the next generation of surgical imaging technology
7. Providence St. Vincent bringing IMRISneuro, the worlds most advanced surgical MRI to Portland, Oregon
8. NuVasive Announces Web Cast and Conference Call of Fourth Quarter 2008 Results
9. Webcast Alert: Usinas Siderurgicas de Minas Gerais S.A. - USIMINAS Announces Fourth Quarter 2008 Earnings Results Webcast
10. PepsiCo Foundation Announces Grant to Save the Children to Address Malnutrition in Developing Nations
11. P&M Corporate Finance Announces Acquisition of Spine Technology Summit, Partners with Robin Young to Present 2009 Conference in Canary Wharf London
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from PsychTests.com reveals that behind the tendency to set ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are recognized ... this recognition are considered among the top 2 percent of lawyers practicing within the ... this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, Burt ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... is proud to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon ... beautiful women in the world, and the most handsome men, look naturally attractive. ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... June 24, 2016 Dehaier Medical Systems Ltd. ... which develops, markets and sells medical devices and wearable ... signed a strategic cooperation agreement with Hongyuan Supply Chain ... Chain") on June 20, 2016, to develop Dehaier,s new ... cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s sales ...
Breaking Medicine Technology: